EMA to Grant Initial Authorization to Gilead's Remdesivir for COVID-19 is Imminent
Shots:
- EMA’s head Guido Rasi stated that an initial authorization could be granted to the Gilead’s remdesivir as a potential treatment for COVID-19. The conditional MAA is expected to be issued in coming days
- Earlier- the EMA has recommended the compassionate use of remdesivir- which allows a drug to be administered to patients even before it has been fully authorized
- Additionally- Guido Rasi stated that other possible treatments that may be available fast are mAbs- that can neutralize the SARS-CoV-2
Click here to read full press release/ article
Ref: Reuters | Image:Gilead
Related News: EMA’s CHMP Recommends Compassionate Use of Gilead’s Remdesivir for COVID-19
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com
